Precision Therapy in Lung Cancer: FAQ on Biomarkers for Immune Checkpoint Inhibitors
Episode Ep 3 13 min 51s

Precision Therapy in Lung Cancer: FAQ on Biomarkers for Immune Checkpoint Inhibitors

In this podcast episode, listen to lung cancer experts Edward S. Kim, MD, FACP, and Leora Horn, MD, MSc, FRCPC, answer audience questions from a live CCO Webinar on the topic of current and evolving biomarkers for immune checkpoint inhibitor–based therapies in advanced NSCLC.

You May Also Like

Community discussion